Nina M. Berkowitz

National Institutes of Health — United States

Medicine · Health Sciences

20h-index3.7kcitations27works12.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mosquito-borne diseases and control(8), Malaria Research and Control(6), Viral Infections and Outbreaks Research(6), Viral Infections and Vectors(6), HIV Research and Treatment(5)

Publications26 total

Safety and pharmacokinetics of N6LS, a broadly neutralising monoclonal antibody for HIV: a phase 1, open-label, dose-escalation study in healthy adults
The Lancet HIV·2025· 4 cited
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine
npj Vaccines·2024· 15 citedOpen Access
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials
npj Vaccines·2024· 18 citedOpen Access
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults
Science Translational Medicine·2023· 89 citedOpen Access
Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial
The Lancet Infectious Diseases·2023· 35 citedOpen Access
Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria
New England Journal of Medicine·2022· 114 citedOpen Access
Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial
EClinicalMedicine·2022· 38 citedOpen Access
Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial
The Lancet Infectious Diseases·2022· 34 citedOpen Access
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial
Nature Medicine·2022· 84 citedOpen Access
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial
Nature Medicine·2022· 153 citedOpen Access
Optimization of the CIS43LS Malarial Monoclonal Antibody and Protection Against Malaria
SSRN Electronic Journal·2022Open Access
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial
The Lancet Respiratory Medicine·2021· 63 citedOpen Access
Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses
Immunity·2021· 64 citedOpen Access
Effect of a Chikungunya Virus–Like Particle Vaccine on Safety and Tolerability Outcomes
JAMA·2020· 103 citedOpen Access
Molecular Dissection Of Human Antibody Responses Following Prefusion-Stabilized RSV F Vaccination
SSRN Electronic Journal·2020Open Access
Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial
The Lancet HIV·2019· 105 citedOpen Access
A proof of concept for structure-based vaccine design targeting RSV in humans
Science·2019· 324 cited
Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study
The Lancet·2019· 123 citedOpen Access
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials
The Lancet·2017· 298 citedOpen Access
Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection
Proceedings of the National Academy of Sciences·2017· 245 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Ingelise J. Gordon(19), Julie E. Ledgerwood(19), Barney S. Graham(19), John R. Mascola(18), LaSonji A. Holman(17), Sarah H. Plummer(16), Pamela Costner(16), Martin R. Gaudinski(16), Cynthia S. Hendel(15), Floreliz Mendoza(15), Laura Novik(14), Galina V. Yamshchikov(14), Kevin Carlton(13), Jason G. Gall(13), Grace Chen(13), Jamie Saunders(12), Somia P. Hickman(12), Judy Stein(12), Emily E. Coates(12), Richard A. Koup(12)